Komori
Human Metabolome Technologies (6090) · InitiativeAdvanced

Joint Research on Health Indicator Biomarkers with Hirosaki University

First written in FY2019. 2 of 5 entries say "Restated". Latest entry: FY2024.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY2021AdvancedFY2022 – FY20242019: 120192020: 120202021: 120212022: 120222023: 020232024: 12024
Same theme, other companies
Joint Development of a Health and Severe Disease Risk Prediction SystemA theme 2 companies write about · 0 as a headwind · 2 as a tailwind

1 other company's latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2024AdvancedAnnual report

    「We will develop predictive models for physical and mental health and the early detection of disease by analysing health information data and metabolomics omics data collected through health screenings conducted in Hirosaki, Aomori Prefecture, including the Iwaki Health Promotion Project and Hirosaki City's Iki-Iki Health Screening.」

    Regarding the joint research with Hirosaki University, we disclosed a new contract period from 1 May 2024 to 30 April 2026 and the development of predictive models for health and the early detection of disease.
  2. FY2022AdvancedAnnual report

    「The Company will use health information data collected through health examinations conducted in the Iwaki district of Hirosaki, Aomori Prefecture, under the Iwaki Health Promotion Project, together with data obtained through metabolome analysis, to search for biomarkers linked to new health indicators and develop health assessment methods.」

    The joint research agreement with Hirosaki University was disclosed as covering the period from 1 April 2019 to 30 April 2024, and development of health indicators and health assessment methods is continuing.
  3. FY2021RestatedAnnual report

    「The Company will use health information data collected through health examinations conducted in the Iwaki district of Hirosaki, Aomori Prefecture, under the Iwaki Health Promotion Project, together with data obtained through metabolome analysis, to search for biomarkers linked to new health indicators and develop health assessment methods.」

    We continue to conduct joint research with Hirosaki University using health information data and metabolome data to develop health indicators and health assessment methods.
  4. FY2020RestatedAnnual report

    「The Company will use health information data collected through health examinations conducted in the Iwaki district of Hirosaki, Aomori Prefecture, under the Iwaki Health Promotion Project, together with data obtained through metabolome analysis, to search for biomarkers linked to new health indicators and develop health assessment methods.」

    The Company continues developing health indicators and health assessment methods through joint research with Hirosaki University conducted from April 2019 to March 2021.
  5. FY2019First statedAnnual report

    「The Company will use health information data collected through health examinations conducted in the Iwaki district of Hirosaki, Aomori Prefecture, under the Iwaki Health Promotion Project, together with data obtained through metabolome analysis, to search for biomarkers linked to new health indicators and develop health assessment methods.」

    Through joint research with Hirosaki University, the Company began developing new health indicators and health assessment methods using health information data and metabolome analysis data.
Moved together

"Introduction of a Performance-Conditioned Deferred-Delivery Restricted Stock Compensation Plan" moved the same way as this thread, in the same document, in 2 of its 5 moves.

222★123
  1. ★This thread
  2. 1Introduction of a Performance-Conditioned Deferred-Delivery Restricted Stock Compensation Plan2×
  3. 2Development of a New Service in the Metabolome Analysis Business2×
  4. 3Capital investment to expand analytical capabilities and accelerate research and development2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Human Metabolome Technologies yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Joint Research on Health Indicator Biomarkers with Hirosaki University | Human Metabolome Technologies,Inc. (6090) | Komori